Expression profiling of fecal colonocytes for RNA-based screening of colorectal cancer

  • Authors:
    • Satoshi Yajima
    • Mie Ishii
    • Hisayuki Matsushita
    • Kazuhiko Aoyagi
    • Kazuhiko Yoshimatsu
    • Hironori Kaneko
    • Nobuko Yamamoto
    • Tatsuo Teramoto
    • Teruhiko Yoshida
    • Yasuhiro Matsumura
    • Hiroki Sasaki
  • View Affiliations

  • Published online on: November 1, 2007     https://doi.org/10.3892/ijo.31.5.1029
  • Pages: 1029-1037
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The early detection of colorectal cancer originating from any part of the colorectum is desirable because this cancer can be cured surgically if diagnosed early. We searched for marker genes for a fecal RNA-based colorectal cancer screening method by comparison of genome-wide expression profiles among cancerous and non-cancerous tissues, and healthy volunteer- and cancer patient-derived colonocytes from the feces, and the peripheral blood. Of 14,564 genes, only 3 (PAP, REG1A, and DPEP1) were selectable as final candidates which were expressed frequently at any stage of this cancer and were suppressed in non-cancerous tissues and also in the peripheral blood and colonocytes of healthy volunteers. Next, we directly compared fecal RNA-expression profiles between colorectal cancer patients and healthy volunteers, and found that most of the genes (92%) expressed in the colonocytes of the cancer patients were not expressed in those of the healthy volunteers. Six genes (SEPP1, RPL27A, ATP1B1, EEF1A1, SFN, and RPS11) selected randomly from 85 cancer patient-derived colonocyte-specific genes were evaluated. In total, reverse transcription-polymerase chain reaction or focused microarray of all those 9 genes detected 18 (78%) of 23 curable colorectal cancers (Dukes stages A-C), 9 or 10 (64% or 71%) of 14 early cancers with no lymph node metastasis (Dukes stage A or B) and 4 (80%) of 5 right-sided cancers. Our extensive gene list provides other markers for fecal RNA-based colorectal cancer screening.

Related Articles

Journal Cover

November 2007
Volume 31 Issue 5

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Yajima, S., Ishii, M., Matsushita, H., Aoyagi, K., Yoshimatsu, K., Kaneko, H. ... Sasaki, H. (2007). Expression profiling of fecal colonocytes for RNA-based screening of colorectal cancer. International Journal of Oncology, 31, 1029-1037. https://doi.org/10.3892/ijo.31.5.1029
MLA
Yajima, S., Ishii, M., Matsushita, H., Aoyagi, K., Yoshimatsu, K., Kaneko, H., Yamamoto, N., Teramoto, T., Yoshida, T., Matsumura, Y., Sasaki, H."Expression profiling of fecal colonocytes for RNA-based screening of colorectal cancer". International Journal of Oncology 31.5 (2007): 1029-1037.
Chicago
Yajima, S., Ishii, M., Matsushita, H., Aoyagi, K., Yoshimatsu, K., Kaneko, H., Yamamoto, N., Teramoto, T., Yoshida, T., Matsumura, Y., Sasaki, H."Expression profiling of fecal colonocytes for RNA-based screening of colorectal cancer". International Journal of Oncology 31, no. 5 (2007): 1029-1037. https://doi.org/10.3892/ijo.31.5.1029